Avicanna (TSE:AVCN) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Avicanna Inc., an international biopharmaceutical company, has successfully paid off its $1,445,000 debt previously owed under the August 2023 Debentures. The company is known for its focus on developing and commercializing cannabinoid-based products across various medical and pharmaceutical segments.
For further insights into TSE:AVCN stock, check out TipRanks’ Stock Analysis page.
